North America Dialysis Market Size to register a growth of 5.1% CAGR

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report North America Dialysis Market, published by KBV research, the North America Dialysis Market would witness market growth of 5.1% CAGR during the forecast period (2018 – 2024).

The Services market dominated the North America Dialysis Market by Products & Services in 2017. The Equipment market is expected to witness a CAGR of 4.7% during (2018 - 2024).

The USA market would dominate the North America Hemodialysis Market by Country by 2024, growing at a CAGR of 3.9 % during the forecast period. The Canada market is expected to witness a CAGR of 4.6% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 6.8% during (2018 - 2024).

The In-center Dialysis market dominated the USA Dialysis Market by End User in 2017, and would achieve a market value of $21,173.1 million by 2024, growing at a CAGR of 4.2 % during the forecast period. Additionally, The Home Dialysis market is expected to witness highest CAGR of 5.6% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/north-america-dialysis-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.